Biopsychosocial Perspective

Impact of the Diagnosis and Treatment
The patient is a 66-year-old, retired, married man who was diagnosed with stage IIIB follicular lymphoma in January 2003. This was treated by chemotherapy and rituximab. However, he had a recurrence in December of the same year. He now wishes advice about chemotherapy, diet, and lifestyle counseling.
According to the case history, the patient has no moodiness, depression, or anxiety. However, in the past 25 years, there has been growing recognition that the diagnosis and treatment of cancer are very stressful for most patients. A quarter of a century ago, in a North American cross-sectional study of all types of cancer and all stages of disease, Derogatis and colleagues found that no fewer than 47% met standardized diagnostic criteria for a psychiatric disorder (in most cases, an adjustment disorder). 1 Unfortunately, despite the increasing availability of psychosocial support, high levels of morbidity continue to be widely reported at diagnosis, during treatment, and at followup. [2] [3] [4] [5] [6] Indeed, a study of 459 Norwegian patients who had survived Hodgkin's disease found that clinically significant anxiety was more common 7 to 10 years after treatment than it had been in the early years after treatment, thereby indicating the need for continuing psychosocial follow-up. 6 Leaving aside studies of children and adults undergoing bone marrow transplantation, little is known of the current prevalence of psychological and psychiatric morbidity in patients with lymphoma. However, clinically, there is no doubt that patients with non-Hodgkin's lymphoma can experience wide-ranging difficulties related to the diagnosis itself, prognostic uncertainty ("the syndrome of Damocles"), chemotherapy-related side effects (nausea, vomiting, anxiety, fatigue, procedural distress, cognitive impairment, body image disturbances, sexual problems), the effects of isolation ("cabin fever"), and the psychosocial and financial impact of recurrent and/or prolonged, hospitalization. A much-neglected aspect concerns the impact of the diagnosis and treatment of the disease on partners and other family members. In breast cancer, for example, the distress level of male partners is higher than that of the patients. 7 Another disorder associated with the diagnosis and treatment of non-Hodgkin's lymphoma is delirium. Mild delirium is almost certainly underdiagnosed in inpatients, and it is not infrequently mistaken for depression. Undiagnosed, and therefore untreated, delirium can be especially distressing for relatives as well as for the patient.
Recurrent disease, as in this case, is often a particularly difficult time for the individual concerned, as well as for the family, not only because of the prospect of further treatment but also because it may bring home the reality of a poor prognosis. Even if it is of a different type, the previous experience of cancer in the family, or in friends, may have a major impact on how one perceives one's own disease. Where the experience has been negative, it can be very enabling to point out the differences between the cancers. In this patient's family, his wife, mother, and sister all have a history of breast cancer; all are alive and appear to be well.
Prevention of Psychosocial Morbidity
It is increasingly clear that much can be done to prevent psychological and psychiatric morbidity. Although, historically, many patients have felt underinformed and that they would have coped better with more information and choice, the needs of patients for information and involvement in decision making should be assessed carefully in each case. In the United Kingdom, several studies have found that between one half and two thirds of patients' concerns go unidentified, and therefore unaddressed, at outpatient oncology clinics (especially emotional and sexual problems). 3 This is very important because the number of unidentified concerns is a good predictor of subsequent psychosocial morbidity. 5 Other important prophylactic factors are the use of coping strategies such as minimization and the fighting spirit as opposed to anxious preoccupation, stoic acceptance, or helplessness. Satisfaction with relationships with health care staff is also associated with better quality of life and adjustment. [5] [6] [7] [8] This patient is married, with a grown-up son and daughter. In terms of life priorities, he states that security and relationships come first. Because social support acts as a buffer against the effects of stressful life events, it would be helpful to assess family and other relationships in detail to ascertain the extent to which this gentleman has close, confiding relationships. In particular, the effect of the illness and treatment on sexual interest and performance should be ascertained.
It would be beneficial also to establish the extent to which he is protecting those around him; he might welcome the opportunity to discuss matters of concern with a health care professional. In addition, it may be that his wife would appreciate the opportunity for professional support. 7 Apparently, the patient usually keeps his feelings to himself and maintains a calm appearance to those around him. He also keeps positive about cancer. Coping strategies such as the fighting spirit and minimization are generally associated with a relatively good quality of life, and it would be important not to undermine these as some health care professionals sometimes appear to wish to do. However, further assessment of his reasons for keeping his feelings to himself would be helpful.
In clinical practice, where a patient is using a minimization strategy to cope with the disease and the partner is coping with anxious preoccupation, it can be beneficial to see the partner on his or her own to address matters of concern, as minimization and anxious preoccupation are mutually incompatible strategies.
During the previous 12 months, in addition to having to cope with the diagnosis and treatment of lymphoma, the patient reports 3 other major life events, namely, "the death of a close family member, retirement, and a change in living conditions." The impact of stressors tends to be synergistic rather than simply additive, and the psychosocial impact of these other events, therefore, should be assessed further.
The patient enjoys fishing, reading, traveling, and exercise. Detailed advice would depend on the treatment he is to receive following the recurrence. However, in general, it is helpful to maintain hobbies and other interests as far as possible. In our experience, many patients find it very helpful to make a plan for the next day, thereby facilitating a sense of meaning and purpose despite disease symptoms, side effects, and an uncertain or unfavorable prognosis. Of course, the plan needs to be flexible to take into account side effects such as neutropenia, nausea, or fatigue. As far as fatigue is concerned, one might suggest that too much or too little should be avoided and that he is the best judge of what constitutes "too much" and "too little"; also, he should be made aware that fatigue may fluctuate from day to day.
Chemotherapy Side Effects, Treatment-Related Anxiety, and Quality of Life
The patient previously underwent 4 cycles of cyclophosphamide, doxorubicin, vincristine, and prednisolone (CHOP) plus rituximab chemotherapy and, following treatment of coronary heart failure, 2 further cycles of rituximab. It is not clear to what extent nausea and vomiting were a problem for him. However, where nausea and vomiting are not well controlled, conditioned nausea, and less commonly conditioned vomiting, may develop: the individual comes to experience these side effects in anticipation of chemotherapy. Typically, this is also associated with increasing treatment-related anxiety, which may affect sleep, appetite, and mood before treatment. In extreme cases, it can lead to premature discontinuation of chemotherapy. 9 Interestingly, a recent study of 273 patients with Hodgkin's disease who were followed up between 1 and 20 years found that nausea and distress were often triggered by reminders of cancer treatment. The best predictor of persistent symptoms was a retrospective report of anticipatory symptoms during treatment. 10 Fortunately, there is good evidence that interventions such as distraction, relaxation therapy, and hypnotherapy can help side effects. Many years ago, we reported a series of 14 patients who had severe side effects (2 were refusing further chemotherapy). With the help of between 2 and 6 sessions of hypnotherapy and relaxation therapy, all were able to complete their prescribed courses of chemotherapy. Moreover, conditioned nausea was improved in 11 of 13 patients, and conditioned vomiting was improved in 9 of 13 patients. Eight and 5 of the 14 patients experienced an improvement in postchemotherapy nausea and vomiting, respectively. 9 A subsequent randomized controlled trial (RCT) of an unselected series of 69 patients with non-Hodgkin's lymphoma, Hodgkin's disease, and testicular teratoma, for many of whom the psychological interventions were prophylactic, also found benefit from relaxation training and hypnotherapy. The patients were randomized at first diagnosis to standard care, standard care plus relaxation therapy, or standard care plus relaxation therapy plus hypnotherapy. Patients randomized to relaxation with or without hypnotherapy did not receive these interventions until after the third cycle of chemotherapy. The very low incidence of nausea and vomiting during the first 3 cycles suggested that good communication and support can minimize chemotherapy-related side effects. 11 Many patients wish to do something for themselves to ensure the best quality of life during and after chemotherapy; hence, this patient's desire for lifestyle counseling. Despite the increasing use of complementary medicine, remarkably few complementary interventions have been subjected to rigorous randomized trials in patients with cancer. Such studies are necessary not only to demonstrate efficacy, effectiveness, and cost-effectiveness but also to establish safety. 12 We are currently evaluating the effects of reflexology and scalp massage in 180 women with early breast cancer, and the study has proven popular with the women (160 recruited to date).
The best-evaluated self-help intervention is probably relaxation therapy. The relaxation response can be construed as the opposite of the fight-flight response, characterized by increased parasympathetic autonomic nervous system tone. 13 Performance usually improves with practice, and patients are given audio cassette recordings for regular practice at home.
A common variant involves a series of muscular tensing exercises designed to produce rebound muscular relaxation, followed by imagery exercises to induce feelings of calmness and confidence. In some programs, patients learn to associate trigger words such as "1, 2, 3, relax" with muscular relaxation so that this cue becomes a powerful self-controlled conditioned stimulus that can be used to switch on the relaxation response at will.
Studies have shown that relaxation therapy has beneficial effects on quality of life during radiotherapy, chemotherapy, and more generally. [14] [15] [16] In a study of 96 women with newly diagnosed locally advanced breast cancer, we combined relaxation with a special type of guided imagery (RT + GI) whereby, while relaxed, the women visualized their white blood cells "attacking" the breast cancer or in some other way promoting improved health. 14 Although we gave them a portfolio of 10 color cartoons depicting various metaphors (eg, fighting spirit, phagocytosis, cleaning up the cancer), we encouraged the women to develop their own images, and many did so.
Women were randomized to individual relaxation and guided imagery plus a high level of support or a high level of support on its own. They received 6 cycles of CHOP chemotherapy, followed by surgery, radiotherapy, and hormone therapy. We carried out comprehensive psychological assessments before chemotherapy and on 11 further occasions over the next 37 weeks. In addition, as we were interested on the putative effects on host defenses, the first 80 patients gave 10 blood samples during this period for immunological analysis.
Between-group analyses demonstrated a number of statistically significant differences. During chemotherapy, women randomized to RT + GI had higher scores of positive mood; they reported significantly better global quality of life (indeed, there was no average deterioration during chemotherapy), and they showed changes in coping. Specifically, they became more assertive and emotionally expressive. This latter finding is of particular interest as the case history suggests the patient usually keeps his feelings to himself. If assessment reveals that he would prefer to be more open about his feelings, RT + GI might be helpful to him in this respect.
A number of statistically significant differences in host defenses were also observed, including an increased number of T cells (CD2+), activated T cells (CD25+), and natural killer cells (CD56+); reduced circulating levels of TNF-α; and, at the final end point (week 37 postdiagnosis), increased lymphokine activated killer cell activity. 17 It is not yet known to what extent these findings are specific to locally advanced breast cancer, and we are currently investigating the effects of relaxation therapy and guided imagery, alone and in combination, in 180 patients undergoing chemotherapy for colorectal cancer.
In this case, it would be appropriate to offer the patient training in relaxation therapy and guided imagery. However, not all patients wish to use self-help techniques, and it is important that he is not made to feel that by declining these he is letting down either himself or his family.
Mental Attitude, Coping, Mood, and Survival
Patients often ask whether psychosocial factors can affect the course of malignant disease, and this is a difficult question to answer on the basis of available data. Some studies have correlated mental attitude and outcome. For example, in a celebrated study, Greer and colleagues assessed mental attitude toward cancer in women with breast cancer and found that those who scored highest on fighting spirit or denial lived longer than did those who coped by means of stoic acceptance, hopelessness/helplessness, or anxious preoccupation. 18 While these are intriguing findings, correlational studies cannot prove that the relationships discovered are causal. For example, it could be that patients with aggressive tumors cope differently from those with more indolent disease either as a reaction to the disease or as a behavioral manifestation of the cancer phenotype.
To date, 11 RCTs have studied the effects of a range of psychological interventions on survival. 19 Of these, 5 have found a prolongation of survival in patients receiving a psychosocial intervention. In our trial of relaxation therapy with or without hypnotherapy described above, 11 we followed up the 63 patients with non-Hodgkin's disease and non-Hodgkin's lymphoma at 5 years and again at 13 years. [20] [21] A multivariate analysis using the Cox proportional hazards model found 4 independent prognostic factors for survival: earlystage disease, low depression scores at diagnosis, low scores on social conformity, and having relaxation therapy with or without hypnotherapy. This is a relatively small study that was not powered to be a survival study. Nonetheless, the results are intriguing. The finding that the interventions apparently prolonged survival is in accordance with 4 other RCTs (advanced breast cancer, malignant melanoma, hematological malignancies, and a mixed group of patients), and the negative prognostic effect of high levels of depression is also of interest as similar findings have been reported in breast and other cancers. 22 Psychosocial interventions might improve survival via a number of different mechanisms, including enhanced treatment compliance, 23 prevention and treatment of mood disorder (as in mortality following poststroke depression), 24 the promotion of a healthier lifestyle, a reduction in infectious complications of treatment, or some direct psychoneuroimmunological effect on the disease. Clearly, further work is needed to confirm these findings and clarify the modus operandi. However, it is essential that we do not promise patients more than has been established; the hypothesis that psychosocial factors can affect clinical outcome is potentially a double-edged sword that can engender guilt as well as bestow power.
Conclusions
Cancer not only affects cells and molecules: it affects people, families, and friends. Whatever the biological effects of psychosocial interventions on various types of cancer transpire to be, it is clear that a great deal can be done already to minimize distress and enhance quality of life by applying existing research findings. 
Integrative Physician's Perspective
The case presented in this issue's Integrative Tumor Board represents a serious disease progression in the history of the patient in question. Recurrent lymphoma, until quite recently, was a situation in which few effective treatment options were available. As Drs Hallmeyer and Peace of the University of Illinois at Chicago outline in their excellent review, this situation is beginning to change. First, however, they discuss some of the considerations for the initial treatment of this patient. Their discussion of the prognostic factors associated with follicular lymphoma is particularly useful, and they offer a good review of the chemotherapeutic options. They bring up the issue of timely restaging. It is my impression that many physicians do not restage sufficiently often during chemotherapy treatment; at our clinic, we restage more frequently in some cases, as often as every 2 months, so that appropriate changes in drug therapy can be instituted. The issue of comorbidities and their impact on treatment choices is something that is frequently overlooked, but these 2 authors do an excellent job in reviewing this topic. The most exciting part of this oncology review, however, is their account of the efficacy that has been noted for the new radioimmunoconjugate drugs, such as Zevalin and Bexxar. The very high response rates of up to 80%, with durations of response over a year, make this class of medications one of the most exciting recent advances in the treatment of lymphomas.
Ms Jenna Wunder and Dr Sara Warber describe the Active Hope Optimal Wellness Program at the University of Michigan. This program is available for leukemia, lymphoma, multiple myeloma, and myelodysplastic syndrome patients. The nutritional program aims to establish basic healthy eating habits that will decrease the proinflammatory state brought about by standard American diets. They rightly point out that dietary interventions might help with some of the comorbidities faced by the patient in this tumor board. Perhaps the most intriguing aspect of the exercise pro-
